Return of Rule Nixing Delivery of Rx Drugs to Medicare Patients Drawing Docs’ Ire
Community oncologists are up in arms about a little-known consequence of the end of the COVID-19 public health emergency (PHE): the return of a rule barring them from mailing or home-delivering chemotherapy drugs to their Medicare patients. The rule comes from a nine-page Frequently Asked Questions (FAQ) document published in September 2021 on the federal […]